Arkolith/Insider Trading/CATX/Form 4

Woods Lori A

DirectorPerspective Therapeutics, Inc. (CATX) · full profile →Form 4 · filed Jun 18, 2024
Net Buying
Open-Market Buys
$50K
Open-Market Sells
$0
Net Open-Market Flow
$50K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 14, 2024Buy(P)5K$10.90$49K160K
Jun 14, 2024Buy(P)83$10.80$896160K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-074592) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML